Accendra Health Share Price (NYSE: ACH)

$3.74

▲

0.05

(1.36%)

Last updated on May 8, 2026 at 1:29 am IST

$₹

Check the interactive Accendra Health Stock chart to analyse performance

Accendra Health Inc Key Stats

Check Accendra Health key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$3.69
Today's High	$3.88
Today's Low	$3.67
Market Capitalization	$287.4M
Revenue TTM	$2.8B
EBITDA	$360.7M
Earnings Per Share (EPS)	$-1.34
Profit Margin	-39.85%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-163.79%

Stock Returns calculator for Accendra Health Stock including INR - Dollar returns

The Accendra Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Accendra Health investment value today

Current value as on today

Returns

(0%)

Returns from Accendra Health Stock

(0%)

Dollar Impact

(0%)

Indian investors sentiment towards Accendra Health Stock

60%

Period: Apr 7, 2026 to May 7, 2026. Change in 30 Days versus previous period

Search interest for Accendra Health Stock from India on INDmoney has increased by 60% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Accendra Health Inc

Name
Holdings %
Name
Holdings %
BNP Paribas Arbitrage, SA
0.01%

Analyst Recommendation on Accendra Health Stock

Rating

Trend

Buy

66%Buy

20%Hold

13%Sell

Based on 15 Wall street analysts offering stock ratings for Accendra Health(by analysts ranked 0 to 5 stars)

Accendra Health Share Price Target

What analysts predicted

Downside of 13.1%

Target:

$3.25

Current:

$3.74

Accendra Health share price target is $3.25, a slight Downside of 13.1% compared to current price of $3.74 as per analysts' prediction.

Accendra Health Stock Insights

Price Movement
In the last 1 month, ACH stock has moved up by 45.3%
Increasing Revenue
Revenue is up for the last 3 quarters, 681.91M → 708.96M (in $), with an average increase of 1.9% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -869.05M → -56.32M (in $), with an average increase of 322.6% per quarter

Accendra Health Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY16

FY17

FY18

FY19

FY20

FY21

FY22

FY23

FY24

FY25

	FY16	Y/Y Change
Revenue	$9.7B	-
Net Income	$108.8M	-
Net Profit Margin	1.12%	-

	FY17	Y/Y Change
Revenue	$9.3B	↓ 4.17%
Net Income	$72.8M	↓ 33.09%
Net Profit Margin	0.78%	↓ 0.34%

	FY18	Y/Y Change
Revenue	$9.4B	↑ 1.07%
Net Income	$-437.0M	↓ 700.35%
Net Profit Margin	-4.64%	↓ 5.42%

	FY19	Y/Y Change
Revenue	$9.2B	↓ 2.2%
Net Income	$-62.4M	↓ 85.73%
Net Profit Margin	-0.68%	↑ 3.96%

	FY20	Y/Y Change
Revenue	$8.5B	↓ 7.93%
Net Income	$29.9M	↓ 147.89%
Net Profit Margin	0.35%	↑ 1.03%

	FY21	Y/Y Change
Revenue	$9.8B	↑ 15.39%
Net Income	$221.6M	↑ 641.82%
Net Profit Margin	2.26%	↑ 1.91%

	FY22	Y/Y Change
Revenue	$10.0B	↑ 1.74%
Net Income	$22.4M	↓ 89.9%
Net Profit Margin	0.22%	↓ 2.04%

	FY23	Y/Y Change
Revenue	$10.3B	↑ 3.8%
Net Income	$-41.3M	↓ 284.47%
Net Profit Margin	-0.4%	↓ 0.62%

	FY24	Y/Y Change
Revenue	$10.7B	↑ 3.55%
Net Income	$-362.7M	↑ 778.15%
Net Profit Margin	-3.39%	↓ 2.99%

	FY25	Y/Y Change
Revenue	$2.8B	↓ 74.19%
Net Income	$-1.1B	↑ 203.47%
Net Profit Margin	-39.85%	↓ 36.46%

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

	Q3 FY23	Q/Q Change
Revenue	$2.6B	-
Net Income	$-6.4M	-
Net Profit Margin	-0.25%	-

	Q4 FY23	Q/Q Change
Revenue	$2.7B	↑ 2.49%
Net Income	$17.8M	↓ 376.75%
Net Profit Margin	0.67%	↑ 0.92%

	Q1 FY24	Q/Q Change
Revenue	$2.6B	↓ 1.64%
Net Income	$-21.9M	↓ 223.07%
Net Profit Margin	-0.84%	↓ 1.51%

	Q2 FY24	Q/Q Change
Revenue	$660.4M	↓ 74.72%
Net Income	$-31.9M	↑ 45.81%
Net Profit Margin	-4.83%	↓ 3.99%

	Q3 FY24	Q/Q Change
Revenue	$686.8M	↑ 4.0%
Net Income	$-12.8M	↓ 59.98%
Net Profit Margin	-1.86%	↑ 2.97%

	Q4 FY24	Q/Q Change
Revenue	$2.7B	↑ 292.53%
Net Income	$-296.1M	↑ 2218.84%
Net Profit Margin	-10.98%	↓ 9.12%

	Q1 FY25	Q/Q Change
Revenue	$2.6B	↓ 2.37%
Net Income	$-25.0M	↓ 91.56%
Net Profit Margin	-0.95%	↑ 10.03%

	Q2 FY25	Q/Q Change
Revenue	$681.9M	↓ 74.09%
Net Income	$-869.1M	↑ 3378.74%
Net Profit Margin	-127.44%	↓ 126.49%

	Q3 FY25	Q/Q Change
Revenue	$697.3M	↑ 2.25%
Net Income	$-150.3M	↓ 82.71%
Net Profit Margin	-21.55%	↑ 105.89%

	Q4 FY25	Q/Q Change
Revenue	$709.0M	↑ 1.68%
Net Income	$-56.3M	↓ 62.52%
Net Profit Margin	-7.94%	↑ 13.61%

FY16

FY17

FY18

FY19

FY20

FY21

FY22

FY23

FY24

FY25

	FY16	Y/Y Change
Profit	$1.2B	-

	FY17	Y/Y Change
Profit	$1.2B	↓ 1.3%

	FY18	Y/Y Change
Profit	$1.1B	↓ 8.65%

	FY19	Y/Y Change
Profit	$1.1B	↑ 5.41%

	FY20	Y/Y Change
Profit	$1.3B	↑ 13.5%

	FY21	Y/Y Change
Profit	$1.5B	↑ 18.14%

	FY22	Y/Y Change
Profit	$1.8B	↑ 20.69%

	FY23	Y/Y Change
Profit	$2.1B	↑ 16.36%

	FY24	Y/Y Change
Profit	$2.2B	↑ 4.42%

	FY25	Y/Y Change
Profit	$1.2B	↓ 45.85%

Q3 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

	Q3 FY23	Q/Q Change
Profit	$538.5M	-

	Q4 FY23	Q/Q Change
Profit	$569.9M	↑ 5.84%

	Q1 FY24	Q/Q Change
Profit	$535.5M	↓ 6.03%

	Q2 FY24	Q/Q Change
Profit	$316.0M	↓ 40.99%

	Q3 FY24	Q/Q Change
Profit	$331.8M	↑ 4.98%

	Q4 FY24	Q/Q Change
Profit	$579.8M	↑ 74.75%

	Q1 FY25	Q/Q Change
Profit	$526.0M	↓ 9.27%

	Q2 FY25	Q/Q Change
Profit	$324.6M	↓ 38.29%

	Q3 FY25	Q/Q Change
Profit	$322.2M	↓ 0.74%

	Q4 FY25	Q/Q Change
Profit	$290.3M	↓ 9.9%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Operating Cash Flow	$339.2M	↑ 104.25%
Investing Cash Flow	$80.1M	↓ 254.29%
Financing Cash Flow	$-379.4M	↑ 191.39%

	FY21	Y/Y Change
Operating Cash Flow	$124.2M	↓ 63.39%
Investing Cash Flow	$-53.6M	↓ 166.98%
Financing Cash Flow	$-129.5M	↓ 65.87%

	FY22	Y/Y Change
Operating Cash Flow	$325.0M	↑ 161.73%
Investing Cash Flow	$-1.8B	↑ 3264.68%
Financing Cash Flow	$1.5B	↓ 1256.26%

	FY23	Y/Y Change
Operating Cash Flow	$740.7M	↑ 127.91%
Investing Cash Flow	$-137.3M	↓ 92.39%
Financing Cash Flow	$-417.3M	↓ 127.88%

	FY24	Y/Y Change
Operating Cash Flow	$161.5M	↓ 78.2%
Investing Cash Flow	$-116.5M	↓ 15.1%
Financing Cash Flow	$-267.6M	↓ 35.88%

	FY25	Y/Y Change
Operating Cash Flow	$-101.8M	↓ 163.03%
Investing Cash Flow	$144.4M	↓ 223.93%
Financing Cash Flow	$188.1M	↓ 170.28%

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

Q3 FY25

Q4 FY25

	Q3 FY24	Q/Q Change
Operating Cash Flow	$27.3M	↓ 76.49%
Investing Cash Flow	$-27.2M	↓ 22.69%
Financing Cash Flow	$-199.6M	↑ 155.1%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$71.0M	↑ 160.01%
Investing Cash Flow	$-52.3M	↑ 92.37%
Financing Cash Flow	$-43.1M	↓ 78.41%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-35.1M	↓ 149.39%
Investing Cash Flow	$-48.2M	↓ 7.85%
Financing Cash Flow	$92.8M	↓ 315.28%

	Q4 FY25	Q/Q Change
Operating Cash Flow	$68.2M	↓ 139.52%
Investing Cash Flow	$285.0M	↓ 822.19%
Financing Cash Flow	$-117.5M	↓ 164.88%

Accendra Health Technicals Summary

Sell

Neutral

Buy

Accendra Health is currently in a neutral trading position according to technical analysis indicators.

Accendra Health Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Accendra Health Inc	43.58%	59.05%	59.05%	59.05%	-77.46%
Cardinal Health, Inc.	-10.99%	-5.98%	30.03%	127.02%	228.29%
Cencora Inc	-21.24%	-29.93%	-10.93%	41.27%	113.59%
McKesson Corporation	-14.64%	-12.71%	7.74%	91.31%	267.92%
Henry Schein, Inc.	-4.09%	0.75%	5.15%	-3.19%	-12.69%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Accendra Health Inc	NA	NA	0.7	0.67	-1.64	0.03	NA	-6.03
Cardinal Health, Inc.	29.28	29.28	1.25	10.77	0.0	0.04	0.01	-12.22
Cencora Inc	36.77	36.77	0.72	17.61	1.33	0.03	0.01	9.81
McKesson Corporation	21.44	21.44	0.98	39.01	0.0	0.04	0.0	-10.55
Henry Schein, Inc.	21.89	21.89	1.6	5.32	0.09	0.04	NA	28.03

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Accendra Health Inc	Buy	$287.4M	-77.46%	NA	-39.85%
Cardinal Health, Inc.	Hold	$44.8B	228.29%	29.28	0.62%
Cencora Inc	Buy	$59.5B	113.59%	36.77	0.5%
McKesson Corporation	Buy	$91.1B	267.92%	21.44	1.09%
Henry Schein, Inc.	Hold	$8.3B	-12.69%	21.89	3.02%

About Accendra Health Inc

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Organization	Accendra Health
Employees	6500
CEO	Mr. Edward A. Pesicka
Industry	Healthcare

Key Management of Accendra Health Inc

Name	Title
Mr. Edward A. Pesicka	President, CEO & Director
Mr. Jonathan A. Leon	Executive VP, CFO & Corporate Treasurer
Mr. Perry A. Bernocchi	Executive VP & COO
Mr. Heath H. Galloway	Executive VP, General Counsel & Corporate Secretary
Will Parrish	Vice President of Strategy of Corporate Development, & Investor Relations
Mr. Dirk Benson	Chief Commercial Officer
Mr. Colin Bain	Chief Products Officer
Trudi Allcott	Director of Media Relations

Important FAQs about investing in ACH Stock from India :

What is Accendra Health share price today?

Accendra Health share price today is $3.74 as on May 8, 2026 at 1:29 am IST at the close of the market. Accendra Health share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Accendra Health share?

Accendra Health share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Accendra Health stock price today i.e. May 8, 2026 at 1:29 am IST is closed at $3.74, lower by 0% versus the 52 week high.

How to invest in Accendra Health Stock (ACH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Accendra Health on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Accendra Health Shares that will get you 0.4011 shares as per Accendra Health share price of $3.74 per share as on May 8, 2026 at 1:29 am IST.

What is the minimum amount required to buy Accendra Health Stock (ACH) from India?

Indian investors can start investing in Accendra Health (ACH) shares with as little as ₹94.2375 or $1 (as of May 08, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹942.38 in Accendra Health stock (as per the Rupee-Dollar exchange rate as on May 08, 2026). Based on Accendra Health share’s latest price of $3.74 as on May 8, 2026 at 1:29 am IST, you will get 2.6738 shares of Accendra Health. Learn more about fractional shares .

What are the returns that Accendra Health has given to Indian investors in the last 5 years?

Accendra Health stock has given -77.46% share price returns and 28.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?